Sullivan, Kelsey
Sullivan, Brynne http://orcid.org/0000-0001-9580-4121
Article History
Received: 25 March 2024
Revised: 1 April 2024
Accepted: 11 April 2024
First Online: 18 April 2024
Competing interests
: MedImmune/AstraZeneca (Gaithersburg, MD, USA) was involved in the trial design, the collection and analysis of the data, and in writing the manuscript, including funding of medical writing support. The study was funded by MedImmune/AstraZeneca and Sanofi (Paris, France).